Lessons Learned From The Outsourcing Of R&Amp;D And Manufacturing Of Potent Apis And Drug Products: Worker Safety And Product Safety Perspectives
- What are the do’s and don’ts for the drug innovator and CMO/CRO/CDMO
- Separating the “Pretenders” from the “Contenders” in your outsourcing strategy
- How to apply the scientific and systematic approach to potent compound safety
- Reviewing the importance of quantitative tools to verify that the facility, work practices and controls are adequate for the API or drug product
- Discussing the impact on speed to market and business risk